scispace - formally typeset
J

Jürgen Peters

Researcher at University of Duisburg-Essen

Publications -  245
Citations -  8908

Jürgen Peters is an academic researcher from University of Duisburg-Essen. The author has contributed to research in topics: Ischemic preconditioning & Sepsis. The author has an hindex of 47, co-authored 243 publications receiving 8031 citations. Previous affiliations of Jürgen Peters include University of Düsseldorf.

Papers
More filters
Journal ArticleDOI

Endovascular stent-graft treatment of penetrating aortic ulcer: results over a median follow-up of 27 months.

TL;DR: In this article, the authors investigated the results of endovascular stent-graft placement for the treatment of patients with Penetrating aortic ulcer (PAU) and concluded that stentgraft treatment is an effective treatment for patients with PAU and is associated with low procedural morbidity.
Journal ArticleDOI

Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: A comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns

TL;DR: Although the maximum degree of withdrawal symptoms on the day after detoxification was similar with both anesthetics, subsequent withdrawal symptoms decreased significantly more rapidly after propofol anesthesia, and a shortened period of long‐term withdrawal symptoms during detoxification.
Journal ArticleDOI

P6 acustimulation effectively decreases postoperative nausea and vomiting in high-risk patients†

TL;DR: Investigation of the effectiveness of acustimulation in relation to known risk factors for PONV revealed a reduction in high-risk patients, that is, when three or four risk factors were present, particularly in patients at high risk.
Journal ArticleDOI

An increased alveolar CD4 + CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality

TL;DR: An increased T-regulatory cell ratio in the admission BAL of patients with ARDS is an important and independent risk factor for 30-day mortality.
Journal ArticleDOI

Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.

TL;DR: Remote ischaemic pre‐conditioning attenuates myocardial injury and sulphonylurea‐treated diabetics are considered to be at risk of heart attack and stroke.